IP Library › Granted Patent US 12,723,266
Granted Patent B2
US 12,723,266 · App. 17/326,891 · Granted Sep 1, 2026

Homology dependent repair genome editing

Inventor: Tomáš Čermák (Brookline, MA)
Assignee: Inari Agriculture Technology, Inc.
C12N15/902C12N9/22C12N15/907C12N2310/20C12N2800/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,723,266
App. No.
17/326,891
Granted
Sep 1, 2026
Kind
B2
Abstract

Eukaryotic cells and related reagents, systems, methods, and compositions for increasing the frequency of homology directed repair (HDR) of target editing sites with genome editing molecules are provided.

Claims (55)

1 . A system for increasing Homology Directed Repair (HDR)-mediated genome modification of a target editing site of a plant cell, comprising:

(a) a plant cell;

(b) heterologous HDR promoting agents comprising a single-stranded DNA annealing protein (SSAP), an exonuclease which can convert a double stranded DNA substrate to a single stranded DNA product, and a single stranded DNA binding protein (SSB); and

(c) genome editing molecule(s) comprising at least one sequence-specific endonuclease which cleaves a DNA sequence in the target editing site or at least one polynucleotide encoding the sequence-specific endonuclease and a donor template DNA molecule having homology to the target editing site;

wherein the plant cell is associated with, contacts, or contains an effective amount of the HDR promoting agents and the genome editing molecule(s).

2 . The system of claim 1 , wherein the genome editing molecules or sequence-specific endonuclease is selected from the group consisting of an RNA-guided nuclease or a polynucleotide encoding an RNA-guided nuclease and a guide RNA or a polynucleotide encoding a guide RNA.

3 . The system of claim 2 , wherein the RNA-guided nuclease is selected from the group consisting of a type II Cas nuclease, a Cas9 nuclease, a type V Cas nuclease, a Cas12a nuclease, a Cas12b nuclease, a Cas12c nuclease, a CasY nuclease, a CasX nuclease, Cas12i, Cas14 and an engineered nuclease.

4 . The system of claim 1 , wherein the SSAP is selected from the group consisting of a RecT/Redβ-, ERF-, and a RAD52-family protein.

5 . The system of claim 4 , wherein the RecT/Redβ-family protein is selected from the group consisting of a Rac bacterial prophage RecT protein, a bacteriophage k beta protein, and a bacteriophage SPP1 35 protein.

6 . The system of claim 4 wherein the exonuclease has 5′ to 3′ exonuclease activity and can recognize a blunt ended dsDNA substrate, a dsDNA substrate having an internal break in one strand, a dsDNA substrate having a 5′ overhang, or a dsDNA substrate having a 3′ overhang.

7 . The system of claim 1 , wherein the exonuclease is selected from the group consisting of bacteriophage lambda exo protein, a Rac prophage RecE exonuclease, an Artemis protein, an Apollo protein, a DNA2 exonuclease, an Exo1 exonuclease, a herpesvirus SOX protein, UL12 exonuclease, an enterobacterial exonuclease VIII, a T7 phage exonuclease, E. coli Exonuclease III, a mammalian Trex2 exonuclease, and a protein having at least 70% sequence identity to SEQ ID NO: 8, 9, 136, 137, 138, 139, 140, 141, 142, 143, 144, or 145.

8 . The system of claim 1 , wherein the SSB has at least 70% sequence identity to SEQ ID NO: 31, 34-131, or 132.

9 . The system of claim 1 , wherein the SSAP is a bacteriophage lambda beta SSAP, the exonuclease is a bacteriophage lambda exonuclease, and the SSB is an E. coli SSB.

10 . The system of claim 1 , wherein the frequency of HDR is increased by at least 2-fold in comparison to a control system wherein a control plant cell is provided with the genome editing molecules but is not exposed to at least one of said HDR promoting agents.

11 . The system of claim 1 , wherein the SSAP, the exonuclease, and/or the single stranded DNA binding protein further comprise an operably linked nuclear localization signal (NLS) or a cell-penetrating peptide (CPP).

12 . The system of claim 11 , wherein the operably linked NLS is selected from the group consisting of SEQ ID NO: 10, SEQ ID NO: 11, SEQ ID NO: 12, SEQ ID NO: 13, SEQ ID NO: 14, SEQ ID NO: 15, and SEQ ID NO: 16.

13 . The system of claim 1 , wherein the plant cell is haploid, diploid, or polyploid.

14 . The system of claim 1 , wherein the plant cell is in a culture medium, in a plant, or in a plant tissue.

15 . The system of claim 1 , wherein the system provides for isolating and/or growing a plant cell, propagule, or plant obtained from the plant cell comprising the genome modification, and wherein the genome of the plant cell, propagule, or plant comprises the genome modification.

16 . A method for making a eukaryotic cell having a genomic modification, comprising:

(a) providing genome editing molecules and heterologous Homology Directed Repair (HDR) promoting agents to a eukaryotic cell, wherein the genome editing molecules comprise: at least one sequence-specific endonuclease which cleaves a DNA sequence in the target editing site or at least one polynucleotide encoding the sequence-specific endonuclease and a donor template DNA molecule having homology to the target editing site;

and wherein the heterologous HDR promoting agents comprise a single-stranded DNA annealing protein (SSAP), an exonuclease which can convert a double stranded DNA substrate to a single stranded DNA product, and a single stranded DNA binding protein (SSB);

whereby the genome editing molecules and HDR promoting agents provide for modification of the target editing site of the eukaryotic cell genome with the donor template DNA by HDR at a frequency that is increased in comparison to a control; and

(b) isolating or propagating a eukaryotic cell comprising the genome modification, thereby making the eukaryotic cell having a genomic modification.

17 . The method of claim 16 , wherein the sequence-specific endonuclease comprises an RNA-guided nuclease or a polynucleotide encoding an RNA-guided nuclease and a guide RNA or a polynucleotide encoding a guide RNA.

18 . The method of claim 16 , wherein the RNA-guided nuclease is selected from the group consisting of a type II Cas nuclease, a Cas9 nuclease, a type V Cas nuclease, a Cas12a nuclease, a Cas12b nuclease, a Cas12c nuclease, a CasY nuclease, a CasX nuclease, and an engineered nuclease.

19 . The method of claim 16 , wherein the donor DNA molecule is provided on a circular DNA vector, geminivirus replicon, or as a linear DNA fragment.

20 . The method of claim 16 , wherein the donor DNA molecule is flanked by an endonuclease recognition sequence.

21 . The method of claim 16 , wherein the SSAP is selected from the group consisting of a RecT/Redβ-, ERF-, and a RAD52-family protein.

22 . The method of claim 21 , wherein the RecT/Redβ-family protein is selected from the group consisting of a Rac bacterial prophage RecT protein, a bacteriophage k beta protein, a bacteriophage SPP1 35 protein, and a protein having at least 70% sequence identity to SEQ ID NO: 1, 2, or 3.

23 . The method of claim 16 , wherein the exonuclease has 5′ to 3′ exonuclease activity and can recognize a blunt ended dsDNA substrate, a dsDNA substrate having an internal break in one strand, a dsDNA substrate having a 5′ overhang, or a dsDNA substrate having a 3′ overhang.

24 . The method of claim 16 , wherein the exonuclease is selected from the group consisting of a bacteriophage lambda exo protein, a Rac prophage RecE exonuclease, an Artemis protein, an Apollo protein, a DNA2 exonuclease, an Exo1 exonuclease, a herpesvirus SOX protein, UL12 exonuclease, an enterobacterial exonuclease VIII, a T7 phage exonuclease, E. coli Exonuclease III, a mammalian Trex2 exonuclease, or a protein having at least 70% sequence identity to SEQ ID NO: 8, 9, 136, 137, 138, 139, 140, 141, 142, 143, 144, or 145.

25 . The method of claim 16 , wherein the SSB has at least 70% sequence identity to SEQ ID NO: 31, 34-131, or 132.

26 . The method of claim 16 , wherein the SSAP is a bacteriophage lambda beta SSAP, the exonuclease is a bacteriophage lambda exonuclease, and the SSB is an E. coli SSB.

27 . The method of claim 16 , wherein the frequency of HDR is increased by at least 2-fold in comparison to a control method wherein a control eukaryotic cell is provided with the genome editing molecules but is not exposed to at least one of said HDR promoting agents.

28 . The method of claim 16 , wherein the frequency of non-homologous end-joining (NHEJ) is maintained or decreased by at least 2-fold in comparison to a control method wherein a control eukaryotic cell is provided with the genome editing molecules but is not exposed to at least one of said HDR promoting agents.

29 . The method of claim 16 , wherein the eukaryotic cell is a mammalian cell or a plant cell.

30 . A method for producing a eukaryotic cell with a genetically modified target editing site comprising:

(a) providing at least one sequence-specific endonuclease which cleaves a DNA sequence at least one endonuclease recognition sequence in said target editing site or at least one polynucleotide encoding said at least one sequence-specific endonuclease, and

(b) providing at least one donor molecule comprising at least one double-stranded DNA sequence, wherein (i) said DNA sequence has a homology of at least 90% over a length of at least 50 nucleotides to sequences flanking the target editing site and (ii) wherein said donor sequence comprises at least one modification in comparison to said target editing site; and

(c) providing at least one heterologous Homology Directed Repair (HDR) promoting agent comprising

(i) at least one single-stranded DNA annealing protein (SSAP), and

(ii) at least one exonuclease which can convert a double stranded DNA substrate to a single stranded DNA product, and

(iii) at least one single stranded DNA binding protein (SSB);

and whereby the at least one sequence-specific endonucleases, the at least one donor molecule, and the at least one HDR promoting agent introduce said modification into said target editing site of said eukaryotic cell; and

(d) isolating a eukaryotic cell comprising a modification in said target editing site.

31 . The method of claim 30 , wherein the modification is selected from the group consisting of an insertion of one or more nucleotides, a deletion of one or more nucleotides, or a substitution of one or more nucleotides.

32 . The method of claim 30 , wherein a portion of the target editing site is deleted by using two sequence specific cleavages in said target editing site, and is replaced by a sequence provided by the donor molecule.

33 . The method of claim 30 , wherein said donor sequence is in a vector flanked by endonuclease recognition sequences.

34 . The method of claim 30 , wherein the method further comprises propagating the eukaryotic cell comprising the modification.

35 . The method of claim 30 , wherein the at least one SSAP is a bacteriophage lambda beta SSAP, the at least one exonuclease is a bacteriophage lambda exonuclease, and the at least one SSB is an E. coli SSB.

36 . A method of producing a genetically modified organism comprising the steps of

(i) producing a genetically modified eukaryotic cell by the method of claim 30 , and

(ii) regenerating said cell into an organism.

37 . The method of claim 36 , wherein the organism is selected from the group consisting of plants and non-human animals.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2021
From: INARI AGRICULTURE, INC.
To: INARI AGRICULTURE TECHNOLOGY, INC.
Reel/Frame 057507/0633 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 26, 2021
From: CERMÁK, TOMÁS
To: INARI AGRICULTURE, INC.
Reel/Frame 057299/0756 →
Continuity (3)
Continuation 16911156 · Jun 24, 2020
Provisional Application 62866317 · Jun 25, 2019
Related Publication 20210277422A1 · Sep 9, 2021
References Cited (241)
US 5310667A · Eichholtz et al. · 1994 [cited by applicant]
US 5322938A · McPherson et al. · 1994 [cited by applicant]
US 5366892A · Foncerrada et al. · 1994 [cited by applicant]
US 5593881A · Thompson et al. · 1997 [cited by applicant]
US 5602321A · John · 1997 [cited by applicant]
US 5641876A · McElroy et al. · 1997 [cited by applicant]
US 5703049A · Rao · 1997 [cited by applicant]
US 5723756A · Peferoen et al. · 1998 [cited by applicant]
US 5736514A · Tizuka et al. · 1998 [cited by applicant]
US 5747450A · Ohba et al. · 1998 [cited by applicant]
US 5792931A · Duvick et al. · 1998 [cited by applicant]
US 5850016A · Jung et al. · 1998 [cited by applicant]
US 5858742A · Fraley et al. · 1999 [cited by applicant]
US 5866775A · Eichholtz et al. · 1999 [cited by applicant]
US 5885801A · Rao · 1999 [cited by applicant]
US 5885802A · Rao · 1999 [cited by applicant]
US 5990389A · Rao et al. · 1999 [cited by applicant]
US 6090627A · Kemp et al. · 2000 [cited by applicant]
US 6225114B1 · Eichholtz et al. · 2001 [cited by applicant]
US 6248876B1 · Barry et al. · 2001 [cited by applicant]
US 6453242B1 · Eisenberg et al. · 2002 [cited by applicant]
US 6479626B1 · Kim et al. · 2002 [cited by applicant]
US 6534261B1 · Cox et al. · 2003 [cited by applicant]
US 6794136B1 · Eisenberg et al. · 2004 [cited by applicant]
US 6867293B2 · Andrews et al. · 2005 [cited by applicant]
US 6903185B2 · Kim et al. · 2005 [cited by applicant]
US RE39247E · Barry et al. · 2006 [cited by applicant]
US 7151204B2 · Houmard et al. · 2006 [cited by applicant]
US 7153949B2 · Kim et al. · 2006 [cited by applicant]
US 7169970B2 · Warner et al. · 2007 [cited by applicant]
US 7361811B2 · Meyer et al. · 2008 [cited by applicant]
US 7626077B2 · Held et al. · 2009 [cited by applicant]
US 8697359B1 · Zhang · 2014 [cited by applicant]
US 8771945B1 · Zhang · 2014 [cited by applicant]
US 8795965B2 · Zhang · 2014 [cited by applicant]
US 8865406B2 · Zhang et al. · 2014 [cited by applicant]
US 8871445B2 · Cong et al. · 2014 [cited by applicant]
US 8889356B2 · Zhang · 2014 [cited by applicant]
US 8889418B2 · Zhang et al. · 2014 [cited by applicant]
US 8895308B1 · Zhang et al. · 2014 [cited by applicant]
US 8906616B2 · Zhang et al. · 2014 [cited by applicant]
US 8932814B2 · Cong et al. · 2015 [cited by applicant]
US 8945839B2 · Zhang · 2015 [cited by applicant]
US 8993233B2 · Zhang et al. · 2015 [cited by applicant]
US 8999641B2 · Zhang et al. · 2015 [cited by applicant]
US 9215849B2 · Chan et al. · 2015 [cited by applicant]
US 9464124B2 · Bancel et al. · 2016 [cited by applicant]
US 9677082B2 · Chintamanani et al. · 2017 [cited by applicant]
US 9738897B2 · Schoenherr et al. · 2017 [cited by applicant]
US 9944925B2 · Konieczka et al. · 2018 [cited by applicant]
US 11041172B2 · Cermak · 2021 [cited by examiner]
US 20020192813A1 · Conner et al. · 2002 [cited by applicant]
US 20080050506A1 · Manjunath et al. · 2008 [cited by applicant]
US 20100311168A1 · Samuel et al. · 2010 [cited by applicant]
US 20110093982A1 · Samuel et al. · 2011 [cited by applicant]
US 20110247100A1 · Samboju et al. · 2011 [cited by applicant]
US 20120023619A1 · Samboju et al. · 2012 [cited by applicant]
US 20120244569A1 · Samuel et al. · 2012 [cited by applicant]
US 20130145488A1 · Wang et al. · 2013 [cited by applicant]
US 20130185823A1 · Kuang et al. · 2013 [cited by applicant]
US 20130210681A1 · Zhang et al. · 2013 [cited by applicant]
US 20140096284A1 · Martin-Ortigosa et al. · 2014 [cited by applicant]
US 20140287509A1 · Sharei et al. · 2014 [cited by applicant]
US 20140356414A1 · Wang et al. · 2014 [cited by applicant]
US 20150040268A1 · Lapidot et al. · 2015 [cited by applicant]
US 20150047074A1 · Strano et al. · 2015 [cited by applicant]
US 20150059010A1 · Cigan et al. · 2015 [cited by applicant]
US 20150082478A1 · Cigan et al. · 2015 [cited by applicant]
US 20150089681A1 · Van Der Oost et al. · 2015 [cited by applicant]
US 20150208663A1 · Khodakovskaya et al. · 2015 [cited by applicant]
US 20150344912A1 · Kim et al. · 2015 [cited by applicant]
US 20160138008A1 · Doudna et al. · 2016 [cited by applicant]
US 20160145631A1 · Voytas et al. · 2016 [cited by applicant]
US 20160208243A1 · Zhang et al. · 2016 [cited by applicant]
US 20160208271A1 · Cigan et al. · 2016 [cited by applicant]
US 20170121722A1 · Anand et al. · 2017 [cited by applicant]
US 20170175140A1 · Hummel et al. · 2017 [cited by applicant]
US 20170260513A1 · Silva et al. · 2017 [cited by applicant]
US 20170273284A1 · Shen · 2017 [cited by applicant]
US 20170275636A1 · Gilbertson et al. · 2017 [cited by applicant]
US 20180230494A1 · Joung et al. · 2018 [cited by applicant]
US 20180273932A1 · Bothmer et al. · 2018 [cited by applicant]
US 20180298392A1 · Cotta-Ramusino · 2018 [cited by applicant]
US 20180298421A1 · Carpenter et al. · 2018 [cited by applicant]
US 20190093104A1 · Stark et al. · 2019 [cited by applicant]
CN 108085328A · 2018 [cited by applicant]
WO WO2015026887A1 · 2015 [cited by applicant]
WO WO2015131101A1 · 2015 [cited by applicant]
WO WO2016007347A1 · 2016 [cited by applicant]
WO WO2016100272A1 · 2016 [cited by applicant]
WO WO2017184227A2 · 2018 [cited by applicant]
WO WO2018067846A1 · 2018 [cited by applicant]
WO WO1998020133A2 · 2018 [cited by applicant]
WO WO2018085693A1 · 2018 [cited by applicant]
WO WO2019123014A1 · 2019 [cited by applicant]
WO WO2020003311A1 · 2020 [cited by applicant]
WO WO2020041172A1 · 2020 [cited by applicant]
Gratz et al., (Genetics, vol. 196, 961-971, 2014) (Year: 2014). [cited by examiner]
Mao et al., (Cell. Mol. Life Sci. 74: 1075-1093, 2017) (Year: 2017). [cited by examiner]
Ander et al., (2015). “A Single-Strand Annealing Protein Clamps DNA to Detect and Secure Homology,” PLOS Biology, 13(8):e1002213. [cited by applicant]
Baim et al., (1991). “A chimeric mammalian transactivator based on the lac repressor that is regulated by temperature and isopropyl beta-D-thiogalactopyranoside,” Proc. Natl. Acad. Sci. USA, 88(12):5072-6. [cited by applicant]
Bernad et al., (1989). “A conserved 3′-5′ exonuclease active site in prokaryotic and eukaryotic DNA polymerases,” Cell, 59(1):219-28. [cited by applicant]
Bhaskaran et al., (1990). “Regeneration in Cereal Tissue Culture: a Review,” Crop Sci. 30(6):1328-37. [cited by applicant]
Bressan et al., (2017). “Efficient CRISPR/Cas9-assisted gene targeting enables rapid and precise genetic manipulation of mammalian neural stem cells”, Development, 144(4):635-648. [cited by applicant]
Brettschneider et al., (1997). “Efficient Transformation of Scutellar Tissue of Immature Maize Embryos,” Theoretical and Applied Genetics, 94:737-48. [cited by applicant]
Broothaerts et al., (2005). “Gene transfer to plants by diverse species of bacteria,” Nature, 433:629-33. [cited by applicant]
Brown et al., (1987). “Lac repressor can regulate expression from a hybrid SV40 early promoter containing a lac operator in animal,” Cell 49:603-12. [cited by applicant]
Burstein et al., (2017). “New CRISPR-Cas systems from uncultivated microbes,” Nature, 542(7640):237-41, 28 pages. [cited by applicant]
Cai et al., (2019). “In vivo genome editing rescues photoreceptor degeneration via a Cas9/RecA-mediated homology-directed repair pathway,” Sci Adv., 5(4):eaav3335, 12 pages. [cited by applicant]
Castle et al., (2004). “Discovery and directed evolution of a glyphosate tolerance gene,” Science 304:1151-4. [cited by applicant]
Čermák et al., (2017). “A Multipurpose Toolkit to Enable Advanced Genome Engineering in Plants,” The Plant Cell, 29(6): 1196-1217. [cited by applicant]
Certo et al., (2013). “Coupling endonucleases with DNA endprocessing enzymes to drive gene disruption,” Nat Methods, 9(10):973-5, 10 pages. [cited by applicant]
Chen et al., (2017). “EXO1 suppresses double-strand break induced homologous recombination between diverged sequences in mammalian cells,” DNA Repair, 57:98-106, 21 pages. [cited by applicant]
Choi et al., (2016). “Efficient mRNA delivery with graphene oxide-polyethylenimine for generation of footprint-free human induced pluripotent stem cells,” J. Controlled Release, 235:222-35. [cited by applicant]
Christopherson et al., (1992). “Ecdysteroid-dependent regulation of genes in mammalian cells by a [cited by applicant]
Chung et al., (2017). “Enhanced Integration of Large DNA Into [cited by applicant]
Clark et al., (2005). “Estimating a Nucleotide Substitution Rate for Maize from Polymorphism at a Major Domestication Locus,” Molecular Biology and Evolution, 22(11):2304-12. [cited by applicant]
Cong et al., (2013). “Multiplex Genome Engineering Using CRISPR/Cas Systems,” Science, 339:819-23. [cited by applicant]
Dasgupta et al., (1998). “Co-ordinated expression of multiple enzymes in different subcellular compartments in plants,” Plant J., 16(1):107-16. [cited by applicant]
Degenkolb et al., (1991). “Structural requirements of tetracycline-Tet repressor interaction: determination of equilibrium binding constants for tetracycline analogs with the Tet repressor,” Antimicrob Agents Chemother,… [cited by applicant]
Deuschle et al., (1989). “Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor,” Proc. Natl. Acad. Sci. USA, 86:5400-4. [cited by applicant]
Deuschle et al., (1990). “RNA polymerase II transcription blocked by [cited by applicant]
Dotson et al., (1996). “A phosphonate monoester hydrolase from Burkholderia caryophilli PG2982 is useful as a conditional lethal gene in plants,” Plant J., 10(2):383-92. [cited by applicant]
Ezzat et al., (2011). “PepFect 14, a novel cell-penetrating peptide for oligonucleotide delivery in solution and as solid formulation,” Nucleic Acids Res., 39:5284-98. [cited by applicant]
Fanning et al., (2006). “A dynamic model for replication protein A (Rpa) function in DNA processing pathways,” Nucleic Acid Research, 34(15):4126-37. [cited by applicant]
Ferré-D'Amaré et al., (2014). “Small Self-cleaving Ribozymes,” Cold Spring Harbor Perspectives Biol., 2:a003574, 10 pages. [cited by applicant]
Figge et al., (1988). “Stringent regulation of stably integrated chloramphenicol acetyl transferase genes by [cited by applicant]
Filsinger et al., (2020). “Characterizing the portability of RecT-mediated oligonucleotide recombination,” bioRxiv, 25 pages. [cited by applicant]
Frame et al., (2011). “Genetic Transformation Using Maize Immature Zygotic Embryos,” Methoads in Molecular Biology, 710: 327-41. [cited by applicant]
Fu et al., (2019). “Target-dependent nickase activities of the CRISPR-Cas nucleases Cpf1 and Cas9,” Nat Microbiol., 4(5):888-97, 22 pages. [cited by applicant]
Fuerst et al., (1989). “Transfer of the inducible lac repressor/operator system from [cited by applicant]
Geiser et al., (1986). “The hypervariable region in the genes coding for entomopathogenic crystal proteins ofBacillus thuringiensis: nucleotide sequence of the kurhdl gene of subsp. [cited by applicant]
Gill et al., (1988). “Negative effect of the transcriptional activator GAL4,” Nature, 334:721-4. [cited by applicant]
Giraldo et al., (2014). “Plant nanobionics approach to augment photosynthesis and biochemical sensing,” Nature Materials, 13:400-9. [cited by applicant]
Gossen et al., (1992). “Tight control of gene expression in mammalian cells by tetracycline-responsive promoters,” Proc. Natl. Acad. Sci. USA, 89:5547-51. [cited by applicant]
Guo et al., (2010). “Directed evolution of an enhanced and highly efficient Fokl cleavage domain for zinc finger nucleases,” J. Mol. Biol., 400:96-107. [cited by applicant]
Halpin et al., (1999). “Self-processing 2A-polyproteins—a system for co-ordinate expression of multiple proteins in transgenic plants,” Plant J., 17(4):453-9. [cited by applicant]
Hamada et al., (2018). “Biolistic-Delivery-Based Transient CRISPR/Cas9 Expression Enables in Planta Genome Editing in Wheat.” Scientific Reports, 8(1):14422. [cited by applicant]
Hartlerode et al., (2010). “Mechanisms of double-strand break repair in somatic mammalian cells,” Biochem J ., 423:157-168. [cited by applicant]
Hendel et al., (2015). “Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells,” Nature Biotechnol., 33(9):985-91, 14 pages. [cited by applicant]
Hillen et al., (1989). “Tet repressor-tet operator interaction,” Topics Mol Struc Biol., 10:143-162. [cited by applicant]
Honig et al., (2015). “Transient Expression of Virally Delivered Meganuclease In Planta Generates Inherited Genomic Deletions.” Molecular Plant, 8(8):1292-94. [cited by applicant]
Hu et al., (1987). “The inducible lac operator-repressor system is functional in mammalian cells,” Cell, 48:555-66. [cited by applicant]
Iftode et al., (1999). “Replication Protein A (Rpa): The Eukaryotic Ssb,” Critical Reviews In Biochemistry And Molecular Biology, 34(3):141-180. [cited by applicant]
Ikeuchi et al., (2016). “Plant regeneration: cellular origins and molecular mechanisms,” Development, 143:1442-51. [cited by applicant]
Ishida et al., (2007). “Agrobacterium-mediated Transformation of Maize,” Nature Protocols, 2:1614-21. [cited by applicant]
Iyer et al., (2002). “Classification and evolutionary history of the single-strand annealing proteins, RecT, Redbeta, ERF and RAD52,” Bmc Genomics, 3:8, 11 pages. [cited by applicant]
Jiang et al., (2013). “RNA-guided editing of bacterial genomes using CRISPR-Cas systems,” Nat Biotechnol., 31(3):233-9. [cited by applicant]
Jinek et al., (2012). “A programmable dual RNA-guided DNA endonuclease in adaptive bacterial immunity,” Science, 337(6096):816-21. [cited by applicant]
Jones et al., (1994). “Isolation of the tomato cf-9 gene for resistance to cladosporium fulvum by transposon tagging,” Science, 266:789-93. [cited by applicant]
Kawasaki et al., (1991). “DNA Sequence Recognition by a Eukaryotic Sequence-Specific Endonuclease, Endo.Scel, from [cited by applicant]
Kim et al., (2011). “Graphene Oxide-Polyethylenimine Nanoconstruct as a Gene Delivery Vector and Bioimaging Tool,” Bioconjugate Chem., 22:2558-67. [cited by applicant]
Kim et al., (2012). “Precision genome engineering with programmable DNA-nicking enzymes,” Genome Res., 22(7):1327-33. [cited by applicant]
Kirienko et al., (2012). “Reliable transient transformation of intact maize leaf cells for functional genomics and experimental study,” Plant Physiol., 159(4):1309-18. [cited by applicant]
Kirihara et al., (1988). “Isolation and sequence of a gene encoding a methionine-rich 10-kDa zein protein from maize,” Gene, 71:359-70. [cited by applicant]
Kleinschmidt et al., (1988). “Dynamics of repressor-operator recognition: Tn10-encoded tetracycline resistance control,” Biochemistry, 27:1094-1104. [cited by applicant]
Kosugi et al., (2009). “Six classes of nuclear localization signals specific to different binding grooves of importin alpha,” J Biol Chem., 284(1):478-85. [cited by applicant]
Labow et al., (1990). “Conversion of the lac repressor into an allosterically regulated transcriptional activator for mammalian cells,” Mol Cell Biol, 10:3343-56. [cited by applicant]
Leduc et al., (1996). “Isolated Maize Zygotes Mimicin VivoEmbryonic Development and Express Microinjected Genes When Cultured in Vitro,” Developmental Biology, 177(1):190-203. [cited by applicant]
Lee et al., (1988). “The molecular basis of sulfonylurea herbicide resistance in tobacco,” EMBO J, 7:1241-8. [cited by applicant]
Leonelli et al., (2016). “Transient expression in Nicotiana benthamiana for rapid functional analysis of genes involved in non-photochemical quenching and carotenoid biosynthesis,” The Plant Journal, 88:375-86. [cited by applicant]
Li et al., (2009). “The FAST technique: a simplified Agrobacterium-based transformation method for transient gene expression analysis in seedlings of [cited by applicant]
Li et al., (2015). “Cas9-Guide RNA Directed Genome Editing in Soybean”, Plant Physiology, 169(2):960-970. [cited by applicant]
Li et al., (2016). “TALEN-Mediated Homologous Recombination Produces SiteDirected DNA Base Change and Herbicide-Resistant Rice”, Journal Of Genetics And Genomics, 43(5):297-305. (Manuscript version). [cited by applicant]
Lilley et al. (1989). “Isolation and Primary Structure for a Novel, Methionine-rich Protein from Sunflower seeds ( [cited by applicant]
Lindsay et al., (2016). “CrispRVariants Charts the Mutation Spectrum of Genome Engineering Experiments,” Nature Biotechnology, 34:701-2. [cited by applicant]
Liu et al., (2013). “Advanced Genetic Tools for Plant Biotechnology.” Nature Reviews, Genetics, 14(11):781-93. [cited by applicant]
Long et al., (2018). “Optimization of CRISPR/Cas9 genome editing in cotton by improved sgRNA expression,” Plant Methods, 14:85, 9 pages. [cited by applicant]
Lu et al., (2010). “Arginine-Rich Intracellular Delivery Peptides Synchronously Deliver Covalently and Noncovalently Linked Proteins into Plant Cells,” J. Agric. Food Chem., 58:2288-94. [cited by applicant]
Lynch, (2010). “Evolution of the mutation rate,” Trends Genet., 26(8):345-52, 16 pages. [cited by applicant]
Mahfouz et al., (2011). “De novo-engineered transcription activator-like effector (TALE) hybrid nuclease with novel DNA binding specificity creates double-strand breaks,” Proc. Natl. Acad. Sci. USA, 108:2623-8. [cited by applicant]
Mahfouz et al., (2011). “TALE nucleases and next generation GM crops,” GM Crops, 2:99-103. [cited by applicant]
Martin et al., (1993). “Map-based cloning of a protein kinase gene conferring disease resistance in tomato,” Science, 262:1432-6. [cited by applicant]
Martin-Ortigosa et al., (2014). “Proteolistics: A Biolistic Method for Intracellular Delivery of Proteins,” Transgenic Research, 23(5):743-56. [cited by applicant]
Martin-Ortigosa et al., (2015). “Mesoporous Silica Nanoparticle-Mediated Intracellular Cre Protein Delivery for Maize Genome Editing via loxP Site Excision,” Plant Physiol., 164:537-47. [cited by applicant]
Masumura et al., (1989). “cDNA cloning of an mRNA encoding a sulfur-rich 10 kDa prolamin polypeptide in rice seeds,” Plant Mol. Biol., 12:123-30. [cited by applicant]
Miki et al., (2018). “CRISPR/Cas9-mediated gene targeting in [cited by applicant]
Mindrinos et al., (1994). “The [cited by applicant]
Murphy, (2016). “λ Recombination and Recombineering,” EcoSal Plus, 7(1), 70 pages. [cited by applicant]
Nagle et al., (2018). “Opportunities for Innovation in Genetic Transformation of Forest Trees,” Front Plant Sci., 9:1443, 8 pages. [cited by applicant]
Negrotto et al. (2000). “The use of phosphomannose-isomerase as a selectable marker to recover transgenic maize plants ( [cited by applicant]
Noguchi et al., (2003). “PDX-1 Protein Containing Its Own Antennapedia-Like Protein Transduction Domain Can Transduce Pancreatic Duct and Islet Cells,” Diabetes, 52(7):1732-7. [cited by applicant]
Nuccio et al., (2015). “Chapter 2: Plant Trait Gene Expression Cassette Design,” Recent Advancements in Gene Expression and Enabling Technologies in Crop Plants, pp. 41-77. [cited by applicant]
Nussaume et al., (1991). “Constitutive Nitrate Reductase: a dominant conditional marker for plant genetics,” The Plant J., 1(2):267-74. [cited by applicant]
O'Brian et al., (2011). “Nano-biolistics: a method of biolistic transfection of cells and tissues using a gene gun with novel nanometer-sized projectiles,” BMC Biotechnol., 11:66, 6 pages. [cited by applicant]
Oliva et al., (1992). “Evidence that tetracycline analogs whose primary target is not the bacterial ribosome cause lysis of [cited by applicant]
O'Reilly (2019). “Extensive CRISPR RNA modification reveals chemical compatibility and structure-activity relationships for Cas9 biochemical activity,” Nucleic Acids Res., 47(2):546-58. [cited by applicant]
Paulsen et al., (2017). “Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR-Cas9 genome editing,” Nat Biomed Eng., 1(11):878-88, 27 pages. [cited by applicant]
Pedersen et al., (1986). “Sequence analysis and characterization of a maize gene encoding a high-sulfur zein protein of M [cited by applicant]
Peng et al., (1999). “‘Green revolution’ genes encode mutant gibberellin response modulators,” Nature, 400:256-61. [cited by applicant]
Pyne et al., (2015). “Coupling the CRISPR/Cas9 System with Lambda Red Recombineering Enables Simplified Chromosomal Gene Replacement in [cited by applicant]
Ran et al., (2013). “Genome engineering using the CRISPR-Cas9 system,” Nature Protocols, 8:2281-2308. [cited by applicant]
Rasco-Gaunt et al., (2003). “Characterisation of the expression of a novel constitutive maize promoter in transgenic wheat and maize,” Plant Cell Rep., 21:569-76. [cited by applicant]
Ravi et al., (2014). “A haploid genetics toolbox for [cited by applicant]
Reines et al., (1993). “Elongation factor SII-dependent transcription by RNA polymerase II through a sequence-specific DNA-binding protein,” Proc. Natl. Acad. Sci. USA, 90:1917-21. [cited by applicant]
Reznikoff, (1992). “The lactose operon-controlling elements: a complex paradigm,” Mol Microbiol., 6:2419-22. [cited by applicant]
Roest et al., (1989). “Plant regeneration from protoplasts: a literature review,” Acta Bot. Neerl., 38(1):1-23. [cited by applicant]
Sawatsubashi et al., (2018). “Development of versatile non-homologous end joining-based knock-in module for genome editing,” Scientific Reports, 8:1-10. [cited by applicant]
Schindele et al., (2018). “Transforming plant biology and breeding with CRISPR/Cas9, Cas12 and Cas13,” FEBS Lett., 592(12):1954-67. [cited by applicant]
Schlaman et al., (1997). “Effectiveness of the bacterial gene codA encoding cytosine deaminase as a negative selectable marker in Agrobacterium mediated plant transformation,” Plant Journal, 11(6):1377-85. [cited by applicant]
Schubert et al., (1988). “Cloning of the Alcaligenes eutrophus genes for synthesis of poly-beta-hydroxybutyric acid (PHB) and synthesis of PHB in [cited by applicant]
Sebo et al., (2013). “A simplified and efficient germline-specific CRISPR/Cas9 system for [cited by applicant]
Shao et al., (2017). “Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing [cited by applicant]
Shao et al., (2017). “Supplementary Information: Enhancing CRISPR/Cas9-mediated homology-directed repair in mammalian cells by expressing [cited by applicant]
Shen et al., (2012). “Biomedical Applications of Graphene,” Theranostics, 2:283-94. [cited by applicant]
Shmakov et al., (2015). “Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems,” Mol. Cell, 60:385-97. [cited by applicant]
Sivamani et al., (2019). “A study on optimization of pat gene expression cassette for maize transformation,” Mol Biol Rep, 36:3009-17. [cited by applicant]
Soda et al., (2019). “CRISPR-Cas9 Based Plant Genome Editing: Significance, Opportunities and Recent Advances.” Plant Physiology and Biochemistry, 131:2-11. [cited by applicant]
Svab et al., (1990). “Aminoglycoside-3″-adenyltransferase confers resistance to spectinomycin and streptomycin in Nicotiana tabacum,” Plant Mol Biol., 14:197-205. [cited by applicant]
Tran et al., (2019). “Enhancement of Precise Gene Editing by the Association of Cas9 With Homologous Recombination Factors,” Front Genet., 10:365, 13 pages. [cited by applicant]
Trehin et al., (2004). “Cellular uptake but low permeation of human calcitonin-derived cell penetrating peptides and Tat (47-57) through well-differentiated epithelial models,” Pharm. Research, 21: 1248-56. [cited by applicant]
Unnamalai et al., (2004). “Cationic oligopeptide-mediated delivery of dsRNA for post-transcriptional gene silencing in plant cells,” FEBS Letters, 566:307-10. [cited by applicant]
Urnov et al., (2010). “Genome Editing with Engineered Zinc Finger Nucleases.” Nature Reviews Genetics, 11(9): 636-46. [cited by applicant]
Urwin et al., (1998). “Enhanced transgenic plant resistance to nematodes by dual proteinase inhibitor constructs,” Planta, 204(4):472-9. [cited by applicant]
Van Eck et al., (2019). “Agrobacterium tumefaciens-Mediated Transformation of Tomato,” Methods in Molecular Biology, 1864:225-34. [cited by applicant]
Verma et al., (1998). “Modified oligonucleotides: synthesis and strategy for users,” Annu. Rev. Biochem., 67:99-134. [cited by applicant]
Vidarsson et al., (2014). “IgG subclasses and allotypes: from structure to effector functions,” Front Immunol., 5:520, 17 pages. [cited by applicant]
Wang et al., (2009). “Biolistic Gun-Mediated Maize Genetic Transformation.” Methods in Molecular Biology, 526: 29-45. [cited by applicant]
Wang et al., (2010). “Aptamer/Graphene Oxide Nanocomplex for in Situ Molecular Probing in Living Cells,” J. Am. Chem. Soc. Comm., 132:9274-6. [cited by applicant]
Wang et al., (2016). “Defining synonymous codon compression schemes by genome recoding,” Nature, 539:59-64, 38 pages. [cited by applicant]
Wang et al., (2017). “Enhancing Targeted Genomic DNA Editing in Chicken Cells Using the CRISPR/Cas9 System,” PLoS One, 12(1):e0169768, 17 pages. [cited by applicant]
Wang et al., (2018). “Transgenerational CRISPR-Cas9 Activity Facilitates Multiplex Gene Editing in Allopolyploid Wheat,” The CRISPR Journal, 1(1):65-74. [cited by applicant]
Wender et al., (2000). “The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters,” Proc. Natl. Acad. Sci. USA, 97:13003-8. [cited by applicant]
White et al., (1990). “A cassette containing the bar gene of Streptomyces hygroscopicus: a selectable marker for plant transformation,” Nucl. Acids Res., 18(4):1062. [cited by applicant]
Williamson et al., (1987). “Nucleotide sequence of barley chymotrypsin inhibitor-2 (CI-2) and its expression in normal and high-lysine barley,” Eur. J. Biochem., 165:99-106. [cited by applicant]
Wong et al. (2016). “Lipid Exchange Envelope Penetration (LEEP) of Nanoparticles for Plant Engineering: A Universal Localization Mechanism,” Nano Lett., 16:1161-72. [cited by applicant]
Wu et al., (2014). “TALE nickase mediates high efficient targeted transgene integration at the human multi-copy ribosomal DNA locus,” Biochem Biophys Res Commun, 446(1):261-6. [cited by applicant]
Wyborski et al., (1991). “Analysis of inducers of the [cited by applicant]
Xing et al., (2014). “A CRISPR/Cas9 toolkit for multiplex genome editing in plants,” BMC Plant Biol., 14:327, 12 pages. [cited by applicant]
Yamano et al., (2016). “Crystal Structure of Cpf1 in Complex with Guide RNA and Target DNA,” Cell, 165(4):949-62. [cited by applicant]
Yan et al., (2019). “Functionally diverse type V CRISPR-Cas systems,” Science, 363(6422):88-91. [cited by applicant]
Yao et al., (1992). “ [cited by applicant]
Yarranton, (1992). “Inducible vectors for expression in mammalian cells,” Curr Opin Biotech, 3:506-11. [cited by applicant]
Yin et al., (2017). “Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing,” Nat. Biotechnol., 35(12):1179-87, 22 pages. [cited by applicant]
Yin et al., (2019). “Single-Stranded DNA-Binding Protein and Exogenous RecBCD Inhibitors Enhance Phage-Derived Homologous Recombination in Pseudomonas,” iScience, 14:1-14, 39 pages. [cited by applicant]
Zambretti et al., (1992). “A mutant p53 protein is required for maintenance of the transformed phenotype in cells transformed with p53 plus ras cDNAs,” Proc. Natl. Acad. Sci. USA, 89:3952-6. [cited by applicant]
Zender et al., (2002). “VP22-mediated intercellular transport of p53 in hepatoma cells in vitro and in vivo,” Cancer Gene Ther., 9(6):489-96. [cited by applicant]
Zetsche et al., (2015). “Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system,” Cell, 163:759-71. [cited by applicant]
Zhang et al., (2007). “Cationic lipids and polymers mediated vectors for delivery of siRNA” J. Controlled Release, 123:1-10. [cited by applicant]
Zhang et al., (2016). “Efficient and Transgene-Free Genome Editing in Wheat through Transient Expression of CRISPR/Cas9 DNA or RNA.” Nature Communications, 7:12617, 8 pages. [cited by applicant]
Zhao et al., (2016). “In Vivo Bio-distribution and Efficient Tumor Targeting of Gelatin/Silica Nanoparticles for Gene Delivery,” Nanoscale Res. Lett., 11:195, 9 pages. [cited by applicant]